Croma-Pharma GmbH Announces Strategic Milestone as Novaestiq Corp. Joins Waldencast
_Saypha® injectables to launch in the U.S. under the Obagi Medical brand, expanding global reach of Cromas science-driven aesthetic solutions_
Croma-Pharma GmbH, a global leader in minimally invasive aesthetic medicine, today!-->…
Weiterlesen...
Weiterlesen...